These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 21316966)
1. The identification of Landouzy-Dejerine disease: an investigative history. Jacqueline M Neuromuscul Disord; 2011 Apr; 21(4):291-7. PubMed ID: 21316966 [No Abstract] [Full Text] [Related]
2. Why did the heated discussion arise between Erb and Landouzy-Dejerine concerning the priority in describing the facio-scapulo-humeral muscular dystrophy and what is the main reason for this famous discussion? Kazakov V Neuromuscul Disord; 2001 May; 11(4):421. PubMed ID: 11369197 [No Abstract] [Full Text] [Related]
3. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes]. Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016 [TBL] [Abstract][Full Text] [Related]
4. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion. Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970 [TBL] [Abstract][Full Text] [Related]
5. Facioscapulohumeral muscular dystrophy (landouzy-dejerine type) in a Nigerian female: a case report. Anisiuba BC; Onwuekwe I; Ejim EC Niger J Med; 2006; 15(3):329-32. PubMed ID: 17111772 [TBL] [Abstract][Full Text] [Related]
6. Charles E. Beevor's lasting contributions to neurology: More than just a sign. McCarter SJ; Burkholder DB; Klaas JP; Boes CJ Neurology; 2018 Mar; 90(11):513-517. PubMed ID: 29530958 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic image (53). Facioscapulohumeral muscle dystrophy]. de Visser M Ned Tijdschr Geneeskd; 2001 Sep; 145(35):1690. PubMed ID: 11561486 [TBL] [Abstract][Full Text] [Related]
9. Axillary nerve block for a wrist fracture in a patient with facioscapulohumeral (Landouzy-Dejerine) disease. Mazboudi M; Figueiredo S; Latrech B; Benhamou D Anaesth Crit Care Pain Med; 2017 Dec; 36(6):409-410. PubMed ID: 28756327 [No Abstract] [Full Text] [Related]
10. [Clinical and genetic characteristics of facioscapulohumeral muscular dystrophy Landuzi-Dezherina type 1]. Dadali EL; Sharkova IV; Zernov NV; Rudenskaya GE; Skoblov MY Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):122-128. PubMed ID: 29265097 [TBL] [Abstract][Full Text] [Related]
11. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy. Goto K; Nishino I; Hayashi YK Neuromuscul Disord; 2006 Apr; 16(4):256-61. PubMed ID: 16545566 [TBL] [Abstract][Full Text] [Related]
12. Atypical facet of Möbius syndrome: association with facioscapulohumeral muscular dystrophy. Kolski HK; Leonard NJ; Lemmers RJ; Bamforth JS Muscle Nerve; 2008 Apr; 37(4):526-9. PubMed ID: 18059038 [TBL] [Abstract][Full Text] [Related]
15. [Facioscapulohumeral muscular dystrophy - twelve cases from two pedigrees]. An R; Xu Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Jun; 31(3):402-3. PubMed ID: 24928028 [No Abstract] [Full Text] [Related]
16. Molecular diagnosis of facioscapulohumeral muscular dystrophy. Upadhyaya M; Cooper DN Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336 [TBL] [Abstract][Full Text] [Related]
17. Asymptomatic elevation of serum creatine kinase leading to the diagnosis of 4q35 facioscapulohumeral muscular dystrophy. Zouvelou V; Manta P; Kalfakis N; Evdokimidis I; Vassilopoulos D J Clin Neurosci; 2009 Sep; 16(9):1218-9. PubMed ID: 19502063 [TBL] [Abstract][Full Text] [Related]